Viewing Study NCT04283669


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-25 @ 8:18 PM
Study NCT ID: NCT04283669
Status: COMPLETED
Last Update Posted: 2025-08-27
First Post: 2020-02-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Sponsor: University of Alabama at Birmingham
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module